These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31064750)

  • 1. Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.
    Cohen JI; Manoli I; Dowdell K; Krogmann TA; Tamura D; Radecki P; Bu W; Turk SP; Liepshutz K; Hornung RL; Fassihi H; Sarkany RP; Bonnycastle LL; Chines PS; Swift AJ; Myers TG; Levoska MA; DiGiovanna JJ; Collins FS; Kraemer KH; Pittaluga S; Jaffe ES
    Blood; 2019 Jun; 133(26):2753-2764. PubMed ID: 31064750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases.
    Zhang Y; Liu Y; Xu J; Liang Y; Xu Z
    Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
    Chen CC; Chang KC; Medeiros LJ; Lee JY
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
    Xie Y; Wang T; Wang L
    J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroa vacciniforme-like lymphoproliferative disorder in Korea.
    Han B; Hur K; Ohn J; Kim TM; Jeon YK; Kim YC; Mun JH
    Sci Rep; 2020 Nov; 10(1):19294. PubMed ID: 33168864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA.
    Oh SJ; Lee J; Park JH; Lee JH; Cho J; Ko YH; Lee D
    Ann Dermatol; 2021 Jun; 33(3):222-227. PubMed ID: 34079181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population.
    López de Cáceres CVB; Rodrigues-Fernandes CI; Rendón Henao J; Morais TML; Soares CD; de Almeida OP; Fonseca FP; Delgado-Azañero W
    J Oral Pathol Med; 2021 Jul; 50(6):530-539. PubMed ID: 34097774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
    Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
    Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
    Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
    Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroa Vacciniforme-Like Lymphoproliferative Disorder With Progression to EBV+ Cytotoxic Peripheral T-Cell Lymphoma.
    Lyapichev KA; Sukswai N; Wang XI; Khoury JD; Medeiros LJ
    Am J Dermatopathol; 2020 Sep; 42(9):714-716. PubMed ID: 31313696
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
    Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
    Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases.
    Xu W; Tan J; Cai C; Lei L; Cao X; Zhou H; Xu M
    Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases.
    Liu Y; Ma C; Wang G; Wang L
    J Am Acad Dermatol; 2019 Aug; 81(2):534-540. PubMed ID: 30654082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
    Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroa vacciniforme-like lymphoproliferative disorder with eye involvement.
    Feng X; Li F; Zhang Y; Wang L
    Pediatr Dermatol; 2021 Sep; 38(5):1387-1388. PubMed ID: 34561883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder.
    Wen PF; Zhang M; Wang TT; Liu HJ; Zhang WY; Liu WP; Wang L
    Am J Dermatopathol; 2019 Jan; 41(1):7-15. PubMed ID: 30085959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.